Rare
lephants
Screener
Toggle theme
10x Genomics, Inc.
TXG
·
Technology, Scientific & Technical Instruments, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2019
Total Cash from Operations:
$152.6M
Line Item
Value
% of Total
Capital Expenditures
$5.9M
3.9%
Other Investing
$7.5M
4.9%
Working Capital
$9.3M
6.1%
Net Cash Flow
$129.9M
85.1%
Download CSV
